Journal article
EpCAM immunotherapy versus specific targeted delivery of drugs
Cancers, Vol.10(1), E19
2018
Abstract
The epithelial cell adhesion molecule (EpCAM), or CD326, was one of the first cancer associated biomarkers to be discovered. In the last forty years, this biomarker has been investigated for use in personalized cancer therapy, with the first monoclonal antibody, edrecolomab, being trialled in humans more than thirty years ago. Since then, several other monoclonal antibodies have been raised to EpCAM and tested in clinical trials. However, while monoclonal antibody therapy has been investigated against EpCAM for almost 40 years as primary or adjuvant therapy, it has not shown as much promise as initially heralded. In this review, we look at the reasons why and consider alternative targeting options, such as aptamers, to turn this almost ubiquitously expressed epithelial cancer biomarker into a viable target for future personalized therapy.
Details
- Title
- EpCAM immunotherapy versus specific targeted delivery of drugs
- Authors/Creators
- J. Macdonald (Author/Creator) - Deakin UniversityJ. Henri (Author/Creator) - Deakin UniversityK. Roy (Author/Creator) - Deakin UniversityE. Hays (Author/Creator) - Deakin UniversityM. Bauer (Author/Creator) - Deakin UniversityR. Veedu (Author/Creator) - Murdoch UniversityN. Pouliot (Author/Creator) - The University of MelbourneS. Shigdar (Author/Creator) - Deakin University
- Publication Details
- Cancers, Vol.10(1), E19
- Publisher
- MDPI AG
- Identifiers
- 991005542336607891
- Copyright
- © 2018 by the authors
- Murdoch Affiliation
- Centre for Comparative Genomics
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Metrics
79 File views/ downloads
39 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 2 Chemistry
- 2.145 Biosensors
- 2.145.243 Nanobiosensors
- Web Of Science research areas
- Oncology
- ESI research areas
- Clinical Medicine